Glaukos Corporation (GKOS)
NYSE: GKOS · Real-Time Price · USD
102.00
-1.62 (-1.56%)
At close: Mar 28, 2025, 4:00 PM
97.92
-4.08 (-4.00%)
After-hours: Mar 28, 2025, 8:00 PM EDT
Glaukos Employees
Glaukos had 995 employees as of December 31, 2024. The number of employees increased by 88 or 9.70% compared to the previous year.
Employees
995
Change (1Y)
88
Growth (1Y)
9.70%
Revenue / Employee
$385,408
Profits / Employee
-$147,108
Market Cap
5.77B
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
GKOS News
- 17 days ago - RadiusXR and Glaukos Corporation Announce a New Collaboration With Topcon Healthcare, Inc. and the Launch of Inspire®: A Next-Generation Visual Field Solution - Business Wire
- 4 weeks ago - FDA Sets Decision Date For Glaukos' Keratoconus Treatment Without The Need Of Surgery - Benzinga
- 4 weeks ago - Glaukos Announces FDA Acceptance of NDA Submission for Epioxa™ - Business Wire
- 5 weeks ago - Glaukos Delivers Mixed Q4 Results, Analyst Sees Growing Investor Interest During Transition - Benzinga
- 5 weeks ago - Glaukos Corporation (GKOS) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 5 weeks ago - Glaukos Announces Fourth Quarter and Full Year 2024 Financial Results - Business Wire
- 2 months ago - Glaukos to Release Fourth Quarter and Full Year 2024 Financial Results after Market Close on February 20 - Business Wire
- 2 months ago - Glaukos Announces Positive Clinical Updates for its iDose® Sustained-Release Procedural Pharmaceutical Platform - Business Wire